Company intelligence / Profile preview

BLUU Seafood

Hamburg-Altona, Hamburg, Germanybluu.bio ↗

Ownership: Private
Employees: ~75
Development stage: Preclinical

Overview

BLUU Seafood has developed prototypes of cultivated fish products such as fish fingers and fish balls using proprietary cell lines from Atlantic salmon and rainbow trout. The company operates a pilot plant in Hamburg with scalable bioreactor capacity. Regulatory approval processes are ongoing in Singapore and the US. Initial market entry expected post-regulatory clearance.

Modalities: Cell-based food production (Cultivated fish cells)
Industry: Food & Nutrition

Partnerships

Spin-off from Fraunhofer Research Institution for Marine Biotechnology and Cell Technology EMB

Beyond the preview

Go deeper on BLUU Seafood.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BLUU Seafood.

Explore the full profile